The University of Sydney is a public research university located in Sydney, Australia. Founded in 1850 as Australia's first university, it is regarded as one of the world's leading universities. The university is one of Australia's six sandstone universities.

During the past decade, University of Sydney conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Sydney" #1 sponsor was "University of Sydney" with 11 trials, followed by "Anavex Life Sciences Corp." with 2 trials sponsored, "CuraSen Therapeutics, Inc." with 2 trials sponsored, "Mondelēz International, Inc." with 2 trials sponsored and "Anne Birgitte Raben" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Sydney" #1 collaborator was "University of Sydney" with 7 trials as a collaborator, "Anavex Australia Pty Ltd." with 2 trials as a collaborator, "Anavex Germany GmbH" with 2 trials as a collaborator, "National Health and Medical Research Council, Australia" with 2 trials as a collaborator and "South West Sydney Local Health District" with 2 trials as a collaborator. Other collaborators include 61 different institutions and companies that were collaborators in the rest 70 trials.

According to Clinical.Site data, the most researched conditions in "University of Sydney" are "Obesity" (3 trials), "Alzheimer Disease" (2 trials), "Chronic Kidney Disease" (2 trials), "Fabry Disease" (2 trials) and "Acupuncture" (1 trials). Many other conditions were trialed in "University of Sydney" in a lesser frequency.

Most popular intervention types in "University of Sydney" are "Behavioral" (8 trials), "Drug" (7 trials), "Device" (4 trials), "Procedure" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "CST-103, CST-107, matching placebo" (2 trials), "attention training" (2 trials), "ANAVEX2-73" (1 trials), "Adalimumab (ADA)" (1 trials) and "Adaptive Behavior Assessment System Third Edition (ABAS-3)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Sydney" are 27 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "University of Sydney". 2 are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in University of Sydney, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Sydney, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".

University of Sydney has several departments that took part in Clinical trials: "Rehabilitation Research Centre, University of Sydney" - 3 trials, "Human Nutrition Unit, The University of Sydney" - 2 trials